ChemoMetec
327.00 DKK
+1.24 %
Less than 1K followers
CHEMM
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ChemoMetec
P/E
Median 2019-2025
EV/S
Median 2019-2025
EV/EBIT
Median 2019-2025
Dividend yield
Median 2019-2026
P/B
Median 2019-2026
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Share price (DKK) | 158.00 | 315.00 | 843.50 | 757.00 | 466.00 | 304.60 | 584.50 | 687.50 |
| Shares | 17.4 | 16.9 | 16.9 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
| Market cap | 2,749.5 | 5,309.3 | 14,217.2 | 13,173.7 | 8,109.6 | 5,300.8 | 10,171.7 | 11,964.2 |
| Enterprise value | 2,670.1 | 5,214.7 | 14,069.4 | 12,971.4 | 7,800.1 | 5,008.8 | 9,836.3 | - |
| EV/S | 15.2 | 24.4 | 50.0 | 30.4 | 17.6 | 12.3 | 19.8 | - |
| EV/EBITDA | 41.1 | 56.3 | 103.7 | 58.2 | 31.1 | 26.9 | 38.1 | - |
| EV/EBIT | 49.4 | 67.3 | 121.3 | 63.9 | 33.8 | 29.6 | 41.6 | - |
| P/E | 65.7 | 89.7 | 160.9 | 82.6 | 45.4 | 38.9 | 54.6 | - |
| P/B | 15.86 | 26.19 | 53.65 | 36.88 | 15.21 | 9.38 | 15.11 | 18.33 |
| P/S | 15.7 | 24.8 | 50.6 | 30.8 | 18.3 | 13.0 | 20.5 | - |
| Dividend yield | 8.2 % | 6.5 % | 0.5 % | 0.0 % | 1.3 % | 1.3 % | 1.2 % | 0.0 % |
| Equity ratio | 72.8 % | 77.1 % | 76.8 % | 71.3 % | 81.0 % | 83.5 % | 81.3 % | 83.3 % |
| Gearing ratio | 10.8 % | 1.1 % | 0.9 % | 1.9 % | 1.3 % | 0.7 % | 1.0 % | 0.8 % |